Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study.
- DOI
- 10.1016/j.bvth.2026.100169
- Published
- 2026 Aug
- Container
- Blood vessels, thrombosis & hemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bvth.2026.100169,
title = {Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study.},
author = {Chrisentery-Singleton T and Acharya S and Ahuja S and Amos LE and Chitlur M and Daoud N and Eason A and Escobar M and Fedor C and Gupta S and Kuriakose P and Nasr S and Pennington S and Pruthi RK and Recht M and Robertson A and Quon DV and Wheeler AP and Reding M},
year = {2026},
journal = {Blood vessels, thrombosis \& hemostasis},
doi = {10.1016/j.bvth.2026.100169},
url = {https://doi.org/10.1016/j.bvth.2026.100169}
}RIS
TY - JOUR TI - Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study. AU - Chrisentery-Singleton T AU - Acharya S AU - Ahuja S AU - Amos LE AU - Chitlur M AU - Daoud N AU - Eason A AU - Escobar M AU - Fedor C AU - Gupta S AU - Kuriakose P AU - Nasr S AU - Pennington S AU - Pruthi RK AU - Recht M AU - Robertson A AU - Quon DV AU - Wheeler AP AU - Reding M PY - 2026 JO - Blood vessels, thrombosis & hemostasis DO - 10.1016/j.bvth.2026.100169 UR - https://doi.org/10.1016/j.bvth.2026.100169 ER -
APA
T, C., S, A., S, A., LE, A., M, C., N, D., A, E., M, E., C, F., S, G., P, K., S, N., S, P., RK, P., M, R., A, R., DV, Q., AP, W., & M, R. (2026). Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study.. Blood vessels, thrombosis & hemostasis. https://doi.org/10.1016/j.bvth.2026.100169
Source records
- pubmed · retrieved 2026-09-26T20:04:34.973Z